Apoptosis inhibitor

Details for Australian Patent Application No. 2001239551 (hide)

Owner Sucampo AG

Inventors Mashima, Yukihiko; Ueno, Ryuji

Agent Davies Collison Cave

Pub. Number AU-B-2001239551

PCT Pub. Number WO01/70233

Priority 60191755 24.03.00 US

Filing date 23 March 2001

Wipo publication date 3 October 2001

Acceptance publication date 21 July 2005

International Classifications

A61K 031/557 - Eicosanoids, e.g. leukotrienes

A61P 025/28 Drugs for disorders of the nervous system

A61P 009/10 Drugs for disorders of the cardiovascular system

A61K 031/357 - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61K 031/341 - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

Event Publications

21 July 2005 Application Accepted

  Published as AU-B-2001239551

17 November 2005 Standard Patent Sealed

24 November 2005 Corrigenda

  Applications Accepted - Name Index Under the name Sucampo AG, Application No. 2001239551, under INID (54) correct the title to read Apoptosis inhibiting composition comprising a 15-keto-prostaglandin or derivative thereof

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001239552

2001239550